As of 2026-03-22, the Intrinsic Value of Kaleido Biosciences Inc (KLDO) is -10.59 USD. This KLDO valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.00 USD, the upside of Kaleido Biosciences Inc is -10,592,100.00%.
Based on its market price of 0.00 USD and our intrinsic valuation, Kaleido Biosciences Inc (KLDO) is overvalued by 10,592,100.00%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -10.59 - -10.59 | -10.59 | -10,592,100.00% |
| P/E | (22.41) - (35.04) | (32.09) | -32093786.1% |
| DDM - Stable | (0.01) - (0.03) | (0.02) | -23348.5% |
| DDM - Multi | 0.00 - 0.00 | 0.00 | -100.0% |
| Market Cap (mil) | 0.00 |
| Beta | 442.80 |
| Outstanding shares (mil) | 42.62 |
| Enterprise Value (mil) | -16.78 |
| Market risk premium | 4.60% |
| Cost of Equity | 7,977.62% |
| Cost of Debt | 5.00% |
| WACC | 5.24% |